Bioatla Inc (BCAB) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioatla Inc   (NASDAQ: BCAB)


Bioatla Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bioatla Inc 's ROA in the second quarter of 2026?
Bioatla Inc recorded a cumulative net loss of $-31 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -258.44%.

However, within the Healthcare sector 913 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 4552 to 4586.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -64.96 % -77.29 % -71.81 % -74.12 % -59.88 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -31 -51 -60 -65 -60
Return On Assets (TTM) -258.44 % -305.36 % -249.14 % -194.64 % -133.33 %
BCAB's Total Ranking # 4586 # 4552 # 4572 # 5229 # 4592
Total Assets (TTM) in million 10 9 15 16 27
Seq. Total Assets Change 10.06 % -40.97 % -8.03 % -41.36 % -28.67 %
Seq. Net Income Change - - - - -

BCAB's 5 Years Annual ROA >> Back to BCAB Management Effectiveness >> Compare BCAB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 140
Sector # 914
Overall # 4610

Return On Assets Statistics
High Average Low
-39.03 %
-111.24 %
-309.44 %
(Dec 31 2021)   (Mar 31 2026)



  News about Bioatla Inc Return on Assets ROA

BioAtla Inc (BCAB) Trailing the Markets Performance

In recent developments, BioAtla Inc s shares have been trailing the performance of the entire market. This analysis will explore key events surrounding BioAtla Inc (BCAB) to shed light on the potential factors behind this downturn.Event 1 - JMP Securities Raises Price Target for BCAB StockOn July 16, 2024, JMP Securities raised the price target for BioAtla Inc (NASDAQ:BCAB) stock to a Mkt outperform. This positive rating, based on the firm s analysis, indicates confidence in the company s future prospects. The announcement, made on September 15, 2022, according to finviz, suggests that the stock may have the potential to rebound in the future.



Financial Statements
Bioatla Inc 's Assets $ 10 million BCAB's Balance sheet
Bioatla Inc 's Income $ 0 million Quarterly BCAB's Income Statement
BCAB's Income by Division See BCAB's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -71.81 % -56.38 % -46.91 % -11.04 % -
Total Assets in million 15 52 119 224 252
Y / Y Net Income Change - - - - -
Net Income in million 60 -70 -123 -106 -95
Annual Return On Assets 407.35 % -134.42 % -103.74 % -47.5 % -37.86 %

BCAB's 5 Years Annual ROA >> Back to BCAB Management Effectiveness >> Compare BCAB ROA to its Competitors



Comment on BCAB's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 407.35 % compared to prior year, due to annual net income growth of % to $59.60 million, and due to decline of value in Bioatla Inc 's assets by -71.81 % to $14.63 million, compared to $14.63 a year before.


More Return On Assets Ratios
BCAB's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BCAB's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BCAB's Competitors
Subscribers only: Roa for Bioatla Inc 's Suppliers
Subscribers only: Return On Assets for BCAB's Customers

You may also want to know
BCAB's Roi BCAB's Inventory Turnover Ratio BCAB's Growth Rates BCAB's Dividend Comparisons
BCAB's Profitability Ratios BCAB's Asset Turnover Ratio BCAB's Dividend Growth
BCAB's Roe BCAB's Valuation Ratios BCAB's Financial Strength Ratios BCAB's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-03T09:38:54+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.